The 5-HT(1A) receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum

Journal of Neural Transmission

Volumn 103, Issue 5, 1996, Pages 541-554

  Nomikos, G G ^a   Arborelius, L ^a   Backlund Hook B ^b   Hacksell, U ^b   Svensson, T H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

5 HT(1A); Dopamine; Microdialysis; Nucleus accumbens; Rat; Striatum

Indexed keywords

2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3,4 DIHYDROXYPHENYLACETIC ACID; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; HOMOVANILLIC ACID; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN ANTAGONIST; 5 HYDROXYINDOLEACETIC ACID; DRUG DERIVATIVE; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; METABOLISM; WISTAR RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; CORPUS STRIATUM; DOPAMINE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; INJECTIONS, SUBCUTANEOUS; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 34347367174     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01273152     Document Type: Article

References (50)

1. Aghajanian GK, Bunney BS (1974) Dopaminergic and non-dopaminergic neurons of the substantia nigra: differential responses to putative transmitters. In: Boissier JR, Hippius H, Pichot P (eds) Proceedings, 9th International Congress of the C.I.N.P. Excerpta Medica, Amsterdam, pp 444-452
2. Andén N-E, Nilsson H, Ros E, Thornström U (1983) Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain. Acta Pharmacol Toxicol 52: 51-56
3. 1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn Schmiedebergs Arch Pharmacol 347: 353-362
4. Arborelius L, Nomikos GG, Hacksell U, Svensson TH (1993b) (R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex. Acta Physiol Scand 148: 465-466
5. 1A receptor antagonist (S)-UH-301 blocks the (R)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the rat. J Neural Transm [Gen Sect] 96: 179-186
6. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rat treated acutely or chronically with citalopram. Naunyn Schmiedebergs Arch Pharmacol 352:157-165
7. 1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. Naunyn Schmiedebergs Arch Pharmacol (in press)
8. Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51: 248-251
9. Benloucif S, Galloway MP (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200: 1-8
10. Benloucif S, Keegan MJ, Galloway MP (1993) Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther 265: 373-377
11. 1A receptor antagonist (S)-5-fluoro-2-(dipropylamino)-tetralin: inhibition of (R)-8-hydroxy-2 (dipropylamino)tetralin-induced effects. J Pharmacol Exp Ther 258: 58-65
12. Björk L, Fredriksson A, Hacksell U, Lewander T (1992) Effects of (R)-8-OH-DPAT and the enantiomers of UH-301 on motor activities in the rat: antagonism of (R)-8-OH-DPAT-induced effects. Eur Neuropsychopharmacol 2: 141-147
13. Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15: 217-222
14. Chen N-H, Reith MEA (1995) Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino)tetralin. J Neurochem 64: 1585-1597
15. Clark D, Hjorth S, Carlsson A (1985) Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of evidence. J Neural Transm 62: 1-52
16. Consolazione A, Cuello AC (1982) CNS serotonin pathways. In: Osborne NN (ed) Biology of serotonergic transmission. John Wiley, Chichester, pp 29-61
17. 1A receptors that are negatively coupled to adenylate cyclase. Mol Pharmacol 39: 780-787
18. 3 receptor ligand. Eur J Pharmacol 249: R9-R10
19. De Boer P, Damsma G, Schram Q, Stoof JC, Zaagsma J, Westerink (1992) The effects of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol 345: 144-152
20. Di Chiara G (1990) Brain dialysis of neurotransmitters: a commentary. J Neurosci Meth 103: 343-350
21. Dray A, Gonye TJ, Oakley NR, Tanner T (1976) Evidence for the existence of a raphe projection to the substantia nigra in rat. Brain Res 113: 45-57
22. Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopminergic neurons as studied by in vivo electrochemistry. Neuroscience 24: 19-28
23. Hervé D, Pickel VM, Joh TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435: 71-83
24. 1A-receptor antagonist. J Med Chem 33: 1541-1544
25. 1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci 48: 1779-1786
26. Ichikawa J, Meltzer HY (1995) Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur J Pharmacol 281: 255-261
27. Imperato A, Di Chiara G (1988) Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 156: 385-393
28. Imperato A, Tanda G, Frau R, Di Chiara G (1988) Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 245: 257-264
29. Kelland MD, Freeman AS, Chiodo LA (1990) Serotonergic afferent regulation of the basal physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J Pharmacol Exp Ther 253: 803-811
30. Kelland MD, Freeman AS, Rubin J, Chiodo LA (1993) Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 31: 539-546
31. Le Moal M, Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71: 155-234
32. 1A receptors: respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridisation histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochem Int 19: 453-465
33. Nedergaard S, Bolam JP, Greenfield SA (1988) Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature 333: 174-177
34. Nedergaard S, Flatman JA, Engberg I (1991) Excitation of substantia nigra pars compacta neurones by 5-hydroxytryptamine in-vitro. NeuroReport 2: 329-332
35. Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1989) Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology 2: 273-281
36. Nomikos GG, Damsma G, Wenkstern D, Fibiger HC (1991) Chronic desipramine enhances amphetamine-induced increases in interstital concentrations of dopamine in the nucleus accumbens. Eur J Pharmacol 195: 63-73
37. 1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus. Eur J Pharmacol 216: 373-378
38. Parsons LH, Justice JB Jr (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606: 195-199
39. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney
40. Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346: 205-230
41. Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum, New York
42. Perry KW, Fuller RW (1992) Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci 50: 1683-1690
43. Pessia M, Jiang Z-G, North RA, Johnson SW (1994) Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res 654: 324-330
44. 1A agonist ±8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine. Synapse 18: 218-224
45. Smith CFC, Cutts S (1990) Dopamine agonist activity of 8-OH-DPAT. Arch Int Pharmacodyn 306: 106-113
46. Tanda G, Carboni E, Frau R, Di Chiara G (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 115: 285-288
47. Timmerman W, Tepper PG, Dijkstra D, Stoelwinder H, Grol CJ, Westerink BHC, Horn AS (1991) Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis. Eur J Pharmacol 199: 145-151
48. Yadid G, Pacak K, Kopin IJ, Goldstein DS (1994) Endogenous serotonin stimulates striatal dopamine release in conscious rats. J Pharmacol Exp Ther 270: 1158-1165
49. Zetterström T, Ungerstedt U (1984) Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis. Eur J Pharmacol 97: 29-36
50. Zis AP, Nomikos GG, Damsma G, Fibiger HC (1991) In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in the rat striatum. Psychopharmacology 103: 343-350